About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Zydus Lifesciences Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
29-Oct-2025
06-Nov-2025
Quarterly Results & Inter alia, shall also consider the proposal for raising funds up to Rs. 5,000 Crores (Rupees Five Thousand Crores only) through the issuance of eligible securities of the Company by way of qualified institutions placement(s), rights issue, preferential allotment or a private placement(s) and/or any combination thereof or any other method as may be permitted under applicable laws, subject to the approval of the members of the Company and such regulatory / statutory approvals as may be required. The Board would also consider convening a postal ballot process to seek approval of the shareholders of the Company in respect of the aforesaid proposal, as required.
01-Aug-2025
12-Aug-2025
Quarterly Results
09-May-2025
20-May-2025
Final Dividend & Audited Results
21-Jan-2025
05-Feb-2025
Quarterly Results
30-Oct-2024
12-Nov-2024
Quarterly Results
18-Jul-2024
09-Aug-2024
Quarterly Results
09-May-2024
17-May-2024
Final Dividend & Audited Results
29-Jan-2024
09-Feb-2024
Quarterly Results & Buy Back of Shares
30-Oct-2023
07-Nov-2023
Quarterly Results
31-Jul-2023
11-Aug-2023
Quarterly Results
12-May-2023
18-May-2023
Final Dividend & Audited Results
23-Jan-2023
03-Feb-2023
Quarterly Results
31-Oct-2022
11-Nov-2022
Quarterly Results
03-Aug-2022
10-Aug-2022
Quarterly Results
13-May-2022
20-May-2022
Final Dividend & Audited Results
25-Jan-2022
03-Feb-2022
Quarterly Results
20-Oct-2021
29-Oct-2021
Quarterly Results
03-Aug-2021
11-Aug-2021
Quarterly Results
21-May-2021
27-May-2021
Final Dividend & Audited Results
27-Jan-2021
05-Feb-2021
Quarterly Results
Page
1
of
6
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.